Scientists Identify Genetic Link That May Neutralize HIV Sep 8, 2008
7, 2008) Scientists from the Gladstone Institute of Virology and Immunology (GIVI) and the National Institutes of Allergy and Infectious Diseases (NIAID) have identified a gene that may influence the production of antibodies that neutralize HIV. This new information will likely spur a new approach for making an HIV vaccine that elicits neutralizing antibodies ... The laboratory of GIVI Director Warner C. Greene and a team of scientists from NIAID now demonstrate that Rfv3 is Apobec3, an innate... (Science Daily)
NIAID Describes Challenges, Prospects For An HIV Vaccine Aug 29, 2008
In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily challenging properties of the virus that have made a vaccine elusive and outline the scientific questions that, if answered, could lead to an effective HIV vaccine ... In recent years, the most extensively studied HIV vaccines have aimed to mobilize immune cells called T cells,... (Science Daily)
Discovery opens door for drugs to fight bird flu, other influenza epidemics Aug 26, 2008
The University of Texas at Austin research was supported by a long-standing grant from the NIH Institute of Allergy and Infectious Disease (NIAID). In addition, NIAID has recently awarded a grant to investigators at The University of Texas at Austin and Rutgers to develop antiviral drugs directed against this NS1 binding pocket. (EurekAlert!)
Bacterial Pneumonia Caused Most Deaths In 1918 Influenza Pandemic Aug 21, 2008
20, 2008) The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health ... A future influenza pandemic may unfold in a similar manner, say the NIAID authors, whose paper in the Oct. 1 issue of The Journal of Infectious Diseases is now available online ... "The weight of evidence we examined from both... (Science Daily)
Leishmaniasis Parasites Evade Death By Exploiting Immune Response To Sand Fly Bites Aug 19, 2008
In a new study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, scientists have discovered L. major does its damage by not only evading but also by exploiting the body's wound-healing response to sand fly bites, as reported in the August 15 issue of Science ... "This work changes the textbook picture of the lifecycle of the leishmaniasis parasite, identifying the inflammatory cell known as the neutrophil as the predominant cell... (Science Daily)
Novel Mechanism That Controls The Development Of Autoimmunity Discovered Aug 15, 2008
The scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Allergy and Infectious Diseases (NIAID), both part of the NIH, studied immune system T cells specifically the helper T cell, an immune system component that helps other cells fight infection. They focused on the protein furin, an enzyme that plays an important role in the functioning of T cells. (Science Daily)
Was Pneumonia Real Killer in 1918 Flu Pandemic? Aug 6, 2008
Furthermore, a journal article from researchers with the National Institute of Allergy and Infectious Disease (NIAID) in Bethesda, Md ... "We agree completely that bacterial pneumonia played a major role in the mortality of the 1918 pandemic," Anthony Fauci, author of next month's article and NIAID director, told New Scientist. (Fox News)
Is there still hope for an HIV vaccine? Aug 6, 2008
Last month, the US National Institute of Allergy and Infectious Diseases (NIAID) announced it would not move ahead with a vaccine trial involving 8,500 participants, which was intended to test a candidate with similarities to the one that failed last year. These developments have left the vaccine field reeling, with people in some quarters calling for public funding of AIDS vaccine research to be ended or diverted toward existing HIV treatment and prevention interventions. (AlertNet)
A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control Aug 3, 2008
The Network and NIAID have a close, cooperative working relationship, with shared attention to the intellectual and scientific issues. Contact: Sarah Alexander 206-910-3801. (PR Newswire)
NIH Official: HIV Vaccine Research "Swimming in the Dark" Jul 30, 2008
NIAID director Anthony Fauci discusses AIDS vaccine ... On July 17, a high-ranking official at the U.S. National Institutes of Health (NIH) on a hotly anticipated clinical trial for a government-funded vaccine to combat human immunodeficiency virus (HIV), the bug that causes full-blown AIDS. The announcement by , director of the NIH's National Institute of Allergy and Infectious Diseases (NIAID), was the latest in a in the search for a vaccine the world has been anxiously awaiting for more than... (Scientific American)
New Vaccine May Protect Against All Four Strains Of Dengue Virus Jul 24, 2008
19, 2003) Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have created a promising vaccine against West Nile virus by replacing parts of a distantly related virus with proteins. (Mar. (Science Daily)
GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine Jul 22, 2008
Preclinical work enabling evaluation of GeoVax DNA and MVA vaccines was funded and supported by NIAID, which provided additional support to GeoVax AIDS vaccine development program with a $15 million IPCAVD grant awarded in late 2007. About Vivalis Vivalis (NYSE- Euronext: VLS) is a biopharmaceutical company that provides innovative cell-based solutions to the pharmaceutical industry for the manufacture of vaccines and proteins, and develops drugs for the prevention and treatment of viral... (PR Newswire)
Large Human Trial Of HIV Vaccine Canceled By NIAID Jul 21, 2008
By Anna Boyd 08:13, July 21st 2008. The National Institutes of Health on Thursday canceled a US human trial of a human immunodeficiency virus vaccine doubting its effectiveness and saying it might increase infection. (eFluxMedia)
Booster Vaccination May Help With Possible Future Avian Influenza Pandemic Jul 19, 2008
(June 1, 2004) The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two contracts to support the production and clinical testing of an. (Dec. (Science Daily)
AIDS Vaccine Trial Scaled Back Jul 18, 2008
Instead NIAID said it will plan a smaller, more focused clinical trial designed to see whether the product has a significant effect on the amount of virus in a person's blood ... NIAID said it acted after reviewing the results of the STEP trial, a study of another vaccine that was halted last fall after reports of an increased number of infections among volunteers taking part in the test. (CBS News)
1998: Syphilis Genome Sequenced; 2008: Syphilis on the Rise Jul 18, 2008
At the time, Penelope Hitchcock, the chief of the sexually transmitted disease branch of the National Institute of Allergy and Infectious Diseases (NIAID), hailed the work as critical to developing better drugs. NIAID director Anthony Fauci added the genome would boost efforts to develop a preventative vaccine. (Scientific American)
US scientists scrap major AIDS vaccine test Jul 18, 2008
The National Institute of Allergy and Infectious Diseases (NIAID), part of the government's National Institutes of Health, said after consulting scientists and advocacy groups it "has determined that it will not conduct the HIV vaccine study known as PAVE 100.". "However, NIAID believes the vaccine developed by its Vaccine Research Center (VRC) is scientifically intriguing and sufficiently different from previously tested HIV vaccines to consider testing it in a smaller, more focused clinical... (Sydney Morning Herald -- World)
Researchers Identify Immune Cells That Block Allergic Reactions Jul 17, 2008
(May 1, 2002) Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) have devised a new, experimental approach to treating allergic diseases. In mice, the scientists used a. (Science Daily)
Gene Signatures For Scleroderma Discovered Jul 17, 2008
20, 1998) A National Institute of Allergy and Infectious Diseases (NIAID) grantee in Seattle has found experimental data to support a new hypothesis about the genesis of scleroderma, an autoimmune disorder. (Nov. (Science Daily)
The Buzz on Mosquito Protection Jul 1, 2008
Recent reports from the National Institute of Allergy and Infectious Diseases (NIAID) state that widespread appearance of Dengue Fever in the continental United States is a real possibility. The American Mosquito Control Association (AMCA) is an international organization of nearly 2,000 public health professionals dedicated to preserving health through safe, environmentally-sound mosquito control programs since 1935. (Sebastopol Sonoma West Publishing, CA)
'Neglected Infections Of Poverty' In United States Disable Hundreds Of Thousands Of Americans Annually Jun 26, 2008
28, 2007) A new paper by NIAID scientist Thomas Nutman, M.D., and colleagues reviews network data collected between 1997 and 2004 to determine demographic and travel characteristics of travelers diagnosed with. (May 29, 2008) In an editorial in this month's PLoS Neglected Tropical Diseases, the journal's Editor in Chief, Professor Peter Hotez (George Washington University and Sabin Vaccine Institute) proposes that a. (Science Daily)
NIAID creates HIV vaccine discovery branch Jun 26, 2008
To accelerate the translation of basic discoveries about HIV into advances in vaccine design and evaluation, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has formed a new Vaccine Discovery Branch within the Vaccine Research Program in the Division of AIDS (DAIDS). "There is broad scientific consensus that designing a safe and effective vaccine to prevent HIV infection will require enormous advances beyond present-day... (EurekAlert! -- Business News)
Lyme Disease Spirochetes Tracked in 3D Jun 25, 2008
(June 21, 2001) A new test developed with funding from the National Institute of Allergy and Infectious Diseases (NIAID) has been shown to be highly accurate and sensitive for detecting antibodies to Lyme disease. . (Science Daily)
Potential New Way To Block Inflammation In Autoimmune Disease Discovered Jun 25, 2008
The NIAMS group collaborated with a laboratory in Cardiff, Wales, which had generated genetically engineered mice deficient in DR3, as well as with a research group at the NIH's National Institute of Allergy and Infectious Diseases (NIAID), which has developed mouse models of disease with strong T cell components, such as asthma and multiple sclerosis. "These findings open up new avenues for therapy of these two diseases as well as to other autoimmune diseases in which T cells play a role in... (Science Daily)
Study further defines potential role of fish-based fatty acids in resolving, preventing asthma Jun 24, 2008
Contact: NIAID Office of Communications ... WHO: Alkis Togias, M.D., Chief of the Asthma and Inflammation Section, NIAID Allergy and Inflammation Branch, is available to comment on this article ... CONTACT: To schedule interviews, contact the NIAID Office of Communications, 301-402-1663. (EurekAlert!)
Are HIV Prevention Gels Safe For Pregnant Women, Their Babies? Jun 18, 2008
The National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both components of the U.S. National Institutes of Health, are funding the study. Women, who represent nearly half of the 33. (Science Daily)
Protein Linked To Alzheimer's Disease Also Has Role In HIV Progression Jun 18, 2008
24, 1998) A common genetic mutation significantly delays the progression of HIV disease, scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have found. (Sep. (Science Daily)
Ancient Antibody Molecule Offers Clues To How Humans Evolved Allergies Jun 15, 2008
14, 2008) Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered how evolution may have lumbered humans with allergy problems. The team from the Randall Division of Cell & Molecular Biophysics, King's College London are working on a molecule vital to a chicken's immune system which represents the evolutionary ancestor of the human antibodies that cause allergic reactions. (Science Daily)
Brucella abortus S19 genome sequenced; points toward virulence genes Jun 6, 2008
The preparation and submission of genomic sequences to GenBank and annotation were funded by NIAID Contract HHSN26620040035C to Bruno Sobral. The manuscript is available on-line at. (EurekAlert!)
New West Nile And Japanese Encephalitis 'Pseudoinfectious' Vaccines Produced May 31, 2008
This research was supported by the NIAID through the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; Widman is supported by a fellowship from the James W. McLaughlin Endowment ... 10, 2005) Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have made the surprising discovery that flaviviruses, which cause such ... 19, 2003) Scientists at the National Institute of Allergy and... (Science Daily)
How Common Vaccine Booster Works May 25, 2008
This research was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Journal reference. (Science Daily)
New Hope For HIV Vaccine: Unique HIV Vaccine Formula Elicits Strong Immune Responses May 24, 2008
In this phase I clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), volunteers first received three injections of a DNA vaccine which expresses protective antigens from the HIV virus, followed by two injections of a protein vaccine whose components matched those included in the DNA vaccine ... Our results demonstrate that it is feasible to use this combination approach to achieve this objective, said Phillip Markham, PhD, of ABL, the Principal... (Science Daily)
West Nile Vaccine Breakthrough May 22, 2008
ScienceDaily (May 21, 2008) University of Queensland researchers have made a giant leap forward in the race to develop a vaccine for the potentially debilitating West Nile virus. Associate Professor Alex Khromykh, from UQ's School of Molecular & Microbial Sciences, and colleagues have found a way to generate immune response levels comparable to a live virus vaccine, which could also help suffers of other disease such as dengue fever and Japanese encephalitis. (Science Daily)
Scientists discover how common vaccine booster works May 22, 2008
Contact: NIAID Office of Communications ... In an online paper in the journal Nature, Yale University researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, explain how a common ingredient in many vaccines stimulates and interacts with the immune system to help provide protection against infectious diseases ... D., Program Officer, NIAID Division of Allergy, Immunology and Transplantation, is available to comment on... (EurekAlert!)
First Evidence That Bacteria Get 'Touchy-feely' About Dangerous Biofilms May 21, 2008
(Credit: Courtesy of Rocky Mountain Laboratories, NIAID, NIH). Related Stories. (Science Daily)
AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine May 17, 2008
ED Rebecca Haag's Statement for National HIV Vaccine Awareness Day, May 18 WASHINGTON, May 16 /PRNewswire-USNewswire/ -- Twenty-six years into the AIDS epidemic, someone is newly infected with HIV every 13 minutes in the U.S. On Sunday, May 18, HIV Vaccine Awareness Day, AIDS Action, one of five national partners in the National Institute of Allergy and Infectious Disease (NIAID) HIV Vaccine Research Education Initiative, urges everyone to help end the AIDS epidemic by participating in the... (PR Newswire)
Dr. Anthony Fauci reflects on 25 years of HIV May 16, 2008
Contact: NIAID Office of Communications ... NIAID Director Anthony S. Fauci, M.D., is available to comment ... Contact: To schedule interviews, contact the NIAID Office of Communications at (301) 402-1663. (EurekAlert!)
Neglected Tropical Diseases Rarely Make The Headlines May 15, 2008
28, 2007) A new paper by NIAID scientist Thomas Nutman, M.D., and colleagues reviews network data collected between 1997 and 2004 to determine demographic and travel characteristics of travelers diagnosed with. . (Science Daily)
Immune System Kick-started In Moist Nasal Lining In Sinusitis, Asthma And Colds May 2, 2008
15, 2004) Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have discovered that people with chronic sinus inflammation have. . (Science Daily)
Quick Way To Make Human Monoclonal Antibodies Against Flu Discovered May 2, 2008
The research was supported by the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and National Center for Research Resources (NCRR) ... "With this new technique for making human monoclonal antibodies efficiently and quickly, Drs. Wilson and Ahmed and their colleagues have made a significant advance," says NIAID Director Anthony S. Fauci, M.D. "Their accomplishment opens the way to producing mAbs that potentially could be used diagnostically or therapeutically not only for... (Science Daily)
Studies test new approaches to islet transplantation May 2, 2008
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), components of the NIH, are sponsoring the studies ... NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism ... NIAID also supports research on basic immunology,... (EurekAlert!)
NIAID describes research priorities to fight drug-resistant tuberculosis Apr 23, 2008
Contact: NIAID News Office ... To help in the fight against drug-resistant TB, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has formulated an MDR and XDR TB research agenda ... A summary of the agenda, authored by NIAID Director Anthony S. Fauci, M.D., and members of the NIAID Tuberculosis Working Group, is now available online in The Journal of Infectious Diseases. (EurekAlert!)
Study provides new understanding of forces behind seasonal flu virus evolution Apr 17, 2008
WHAT: Do influenza viruses persist in low levels year-round in the northern and southern hemispheres, or does a new crop of the virus emerge afresh in tropical zones such as Southeast Asia before spreading into temperate regions around the globe" Researchers have provided an answer to this long-standing question: new strains arise each year. The new findings should help public health officials more quickly and accurately determine which strains to include in the annual flu vaccine. The study,... (EurekAlert!)
Potential Blood Test For Chronic Sinusitis Identified Apr 16, 2008
15, 2004) Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have discovered that people with chronic sinus inflammation have. (Oct. (Science Daily)
Air pollution affects respiratory health in children with asthma Apr 16, 2008
Contact: NIAID Office of Communications ... Using data collected from the NIAID Inner-City Asthma Study (ICAS), researchers examined 861 children with persistent asthma, aged 5 to 12 years, living in low-income areas in seven U.S. inner-city communities: Boston, the Bronx, Chicago, Dallas, New York City, Seattle and Tucson ... The study was funded by NIHs National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Environmental Health Sciences (NIEHS), and National... (EurekAlert!)
Vaccine search is vital in HIV/AIDS arsenal Apr 10, 2008
Based on the input of the summit participants, NIAID will review the balance of resources devoted to HIV/AIDS research and make adjustments to match the state of the science. Funding for HIV vaccine research must not be cut. (Atlanta Journal-Constitution -- Opinion)
New And Deadly Viruses Passed Through Sweet Food And Domestic Animals Apr 7, 2008
7, 2005) Working independently, two research teams funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have identified how Nipah and. (Mar. (Science Daily)
State, federal officials to mark completion of Ricketts Laboratory Apr 4, 2008
The NIAID also awarded funds to the University to build a Regional Biocontainment Laboratory at Argonne National Laboratory to support research conducted by the GLRCE.. Small laboratories already existed at the University and Argonne for safely studying infectious microbes, but at 54,100 gross square feet, the new laboratory will enable researchers to study four or more different pathogens at the same time. (Univeristy of Chicago Chronicle, IL)
CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR Mar 29, 2008
The monies will be used to begin clinical studies of a new drug and treatment method, LiSAVIOR. This unique new drug is also known as compound NIAID #11039 and has received a patent from the United States with patent number: 6,821,958 on November 23, 2004. Also, the World International Patent Organization published the International Application Number as PCT/US2005/039528 on November 5, 2006. (PR Newswire)
Discovery About Fertilization Points Way To Possible Malaria Vaccine Mar 27, 2008
11, 2003) The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has reached a milestone in its efforts to support accelerated development of malaria. (Mar. (Science Daily)
Tropical Disease Experts Call For A 'Global Fund To Fight Neglected Tropical Diseases' Mar 27, 2008
28, 2007) A new paper by NIAID scientist Thomas Nutman, M.D., and colleagues reviews network data collected between 1997 and 2004 to determine demographic and travel characteristics of travelers diagnosed with. (Jan. (Science Daily)
Gene Therapy Can Cause Leukemia In Large Animals Mar 24, 2008
(May 16, 2006) Researchers from the University of Pennsylvania and NIAID have successfully restored the immune system in basset pups with X-linked severe combined immunodeficiency (the so-called "bubble-boy". (Aug. (Science Daily)
Merck AIDS Vaccine Failure Threatens Once-Promising US Study Mar 24, 2008
NIAID, the U.S. infectious disease agency, is holding a tomorrow with AIDS researchers from across the country to review its $497-million AIDS vaccine research program, including the ``balance'' of human trials against laboratory research. An earlier scheduled meeting to discuss the government's vaccine test was postponed in February until after the vaccine summit. (Bloomberg)
People With Job's Syndrome Lack Specific Immune Cells Mar 18, 2008
The study was a collaborative effort of investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), both components of NIH. ... In September 2007, NIAID issued a press release about the first major breakthrough ... NIAID scientists and their colleagues had discovered a mutation in the gene that makes a specific protein known to help alert and direct immune system responses to stop... (Science Daily)
Scientists identify new leads for treating parasitic worm disease Mar 17, 2008
A research team supported by the National Institutes of Health (NIH) Roadmap and the National Institute of Allergy and Infectious Diseases (NIAID) has identified chemical compounds that hold promise as potential therapies for schistosomiasis, a parasitic disease that afflicts more than 200 million people worldwide ... The search for new drugs for schistosomiasis is imperative if we are to control this devastating disease that exacts an enormous toll, both in terms of human suffering and economic... (EurekAlert!)
Immune Cells Genetically Engineered Into Potent Weapons For Battling HIV Mar 8, 2008
7, 2008) By outfitting immune-system killer cells with a new pair of genes, scientists at the Albert Einstein College of Medicine of Yeshiva University transformed them into potent weapons that destroy cells infected with HIV, the virus that causes AIDS. Their novel strategy of genetically engineering immune cells to redirect their infection-fighting ability toward killing HIV-infected cells could lead to an entirely new approach for combating AIDS and other viral diseases. After someone is... (Science Daily)
Protein Inhibits Ebola From Reaching Out To Infect Neighboring Cells Mar 7, 2008
20, 2000) Proteins that help clean and organize the inside of certain T cells may assist HIV in spreading through the body, scientists from the National Institute of Allergy and Infectious Diseases (NIAID). . (Science Daily)
Newly Discovered Antibody Can Potently Neutralize Two Viruses, Study Shows Mar 3, 2008
2, 2008) In laboratory experiments, scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and their colleagues supported by the NIH National Institute of Allergy and Infectious Disease (NIAID), have discovered an antibody that neutralizes two viruses classified as henipaviruses ... D., of Dimitrov's group, and their NIAID-supported collaborator Christopher Broder, Ph ... 7, 2005) Working independently, two research teams funded by the National... (Science Daily)
Gene At Intersection Of Stem Cells, Immunity Feb 27, 2008
Collaborating with the NIAID team helped answer the question ... Carl G. Feng and Alan Sher of NIAID, David C. Weksberg of BCM and Dr. Gregory A. Taylor of Duke. (Science Daily)
Gene Defect Causes Immune Deficiency And Balance Disorder Feb 26, 2008
25, 2008) A genetic defect that causes a severe immune deficiency in humans may also produce balance disorders, according to a new study by researchers at the University of Iowa, The Jackson Laboratory and East Carolina University. The study, published online Feb. 21 in the Journal of Clinical Investigation, examined a specialized strain of Jackson Laboratory mice with a mutation that eliminates the production a protein called p22phox. (Science Daily)
HIV Prevention: Tenofovir Gel Safe For Daily Use By Women, New Study Suggests Feb 26, 2008
HPTN 059 was conducted by the Microbicide Trials Network (MTN), a clinical trials network established in 2006 by the National Institute of Allergy and Infectious Diseases (NIAID) with co-funding from the National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). Prior to the establishment of the MTN, HPTN 059 study was led by the NIAID-funded HIV Prevention Trials Network (HPTN), from which... (Science Daily)
Novel approach strips staph of virulence Feb 15, 2008
NIAID () supports basic and applied research to prevent, diagnose, and treat infectious diseases and also supports research on basic immunology, transplantation, and immune-related disorders. NICHD () sponsors research on development, before and after birth; maternal, child, and family health; reproductive biology and population issues; and medical rehabilitation. (EurekAlert!)
Moss Protein Plays Role In Alzheimer's Disease, Researchers Believe Feb 14, 2008
5, 1998) An unusual enzyme never before seen in viruses appears to shield an AIDS-related skin disease virus from the ravages of ultraviolet (UV) radiation and the immune system, according to a study by NIAID. (Aug. (Science Daily)
HIV persists in the gut despite long-term HIV therapy Feb 14, 2008
Because of the importance of the gut to HIV disease, scientists hoped that long-term treatment with antiretroviral drugs could eradicate HIV from the GALT. A new NIAID study, published online by The Journal of Infectious Diseases, has found that this goal seems unlikely with current antiretroviral drugs ... D., of the NIAID Laboratory of Immunoregulation (LIR), Anthony S. Fauci, M.D., LIR chief and NIAID director, and their colleagues intensively studied eight patients receiving effective... (EurekAlert!)
Plan Expedites Alternatives To Animal Testing Feb 13, 2008
(May 10, 2001) National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., unveiled the Institute s global plan to combat three leading infectious killers. The NIAID Global. (Science Daily)
